Phibro Animal Health Corporation $PAHC Shares Sold by Sowell Financial Services LLC

Sowell Financial Services LLC lowered its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 37.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,322 shares of the company’s stock after selling 35,920 shares during the quarter. Sowell Financial Services LLC owned approximately 0.15% of Phibro Animal Health worth $2,400,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of PAHC. Financial Management Professionals Inc. purchased a new stake in Phibro Animal Health in the 2nd quarter valued at $32,000. EverSource Wealth Advisors LLC increased its stake in Phibro Animal Health by 7,671.4% in the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after purchasing an additional 2,685 shares during the period. Tower Research Capital LLC TRC boosted its stake in shares of Phibro Animal Health by 768.2% during the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock worth $118,000 after buying an additional 4,079 shares during the period. State of Wyoming boosted its stake in shares of Phibro Animal Health by 148.8% during the second quarter. State of Wyoming now owns 6,608 shares of the company’s stock worth $169,000 after buying an additional 3,952 shares during the period. Finally, Yousif Capital Management LLC purchased a new position in shares of Phibro Animal Health during the second quarter worth about $200,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on PAHC. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 9th. JPMorgan Chase & Co. increased their price target on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 22nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $31.40.

Phibro Animal Health Stock Up 1.1%

PAHC opened at $38.17 on Monday. The company has a debt-to-equity ratio of 2.32, a current ratio of 3.09 and a quick ratio of 1.35. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The stock has a market capitalization of $1.55 billion, a P/E ratio of 22.99, a P/E/G ratio of 1.08 and a beta of 0.77. The business has a 50 day simple moving average of $41.44 and a 200-day simple moving average of $35.68.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The firm had revenue of $363.89 million during the quarter, compared to analysts’ expectations of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, equities analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th were paid a $0.12 dividend. The ex-dividend date was Wednesday, November 26th. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health’s dividend payout ratio (DPR) is 28.92%.

Insider Buying and Selling

In other Phibro Animal Health news, CEO Jack Bendheim sold 5,752 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $40.93, for a total transaction of $235,429.36. Following the transaction, the chief executive officer directly owned 39,200 shares in the company, valued at approximately $1,604,456. This represents a 12.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders have sold a total of 146,554 shares of company stock worth $6,338,444 over the last quarter. 50.13% of the stock is currently owned by insiders.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.